PDF herunterladen
Semin Neurol 2011; 31(3): 325-337
DOI: 10.1055/s-0031-1287654
© Thieme Medical Publishers

Role of Infection and Neurologic Dysfunction in Chronic Fatigue Syndrome

Anthony L. Komaroff1 , 3 , Tracey A. Cho2 , 3 , 4
  • 1Division of General Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts
  • 2Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts
  • 3Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts
  • 4Harvard Medical School, Boston, Massachusetts
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
30. September 2011 (online)

    Lizenzen und Reprints

ABSTRACT

Chronic fatiguing illnesses following well-documented infections and acute “infectious-like” illnesses of uncertain cause have been reported for many decades. Chronic fatigue syndrome (CFS) was first formally defined in 1988. There is considerable evidence that CFS is associated with abnormalities of the central and autonomic nervous systems. There also is evidence linking several infectious agents with CFS, although no agent has been proven to be a cause of the illness. Most of the infectious agents that have been linked to CFS are able to produce a persistent, often life-long, infection and thus are a constant incitement to the immune system. Most also have been shown to be neuropathogens. The evidence is consistent with the hypothesis that CFS, in some cases, can be triggered and perpetuated by several chronic infections that directly or indirectly affect the nervous system, and that symptoms are a reflection of the immune response to the infection.

KEYWORDS

Chronic fatigue syndrome - neuroendocrine - magnetic resonance imaging - central nervous system - autonomic nervous system - depression - immune activation - mitochondrial dysfunction - Epstein-Barr virus - human herpesvirus 6 - enterovirus

REFERENCES

  • 1 Fukuda K, Straus S E, Hickie I, Sharpe M C, Dobbins J G, Komaroff A. International Chronic Fatigue Syndrome Study Group . The chronic fatigue syndrome: a comprehensive approach to its definition and study.  Ann Intern Med. 1994;  121 (12) 953-959
    CrossrefPubMedGoogle Scholar
  • 2 Reyes M, Nisenbaum R, Hoaglin D C et al.. Prevalence and incidence of chronic fatigue syndrome in Wichita, Kansas.  Arch Intern Med. 2003;  163 (13) 1530-1536
    CrossrefPubMedGoogle Scholar
  • 3 Komaroff A L, Fagioli L R, Doolittle T H et al.. Health status in patients with chronic fatigue syndrome and in general population and disease comparison groups.  Am J Med. 1996;  101 (3) 281-290
    CrossrefPubMedGoogle Scholar
  • 4 Reynolds K J, Vernon S D, Bouchery E, Reeves W C. The economic impact of chronic fatigue syndrome.  Cost Eff Resour Alloc. 2004;  2 (1) 4
    CrossrefPubMedGoogle Scholar
  • 5 Demitrack M A, Dale J K, Straus S E et al.. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome.  J Clin Endocrinol Metab. 1991;  73 (6) 1224-1234
    CrossrefPubMedGoogle Scholar
  • 6 Dinan T G, Majeed T, Lavelle E, Scott L V, Berti C, Behan P. Blunted serotonin-mediated activation of the hypothalamic-pituitary-adrenal axis in chronic fatigue syndrome.  Psychoneuroendocrinology. 1997;  22 (4) 261-267
    CrossrefPubMedGoogle Scholar
  • 7 Scott L V, Medbak S, Dinan T G. The low dose ACTH test in chronic fatigue syndrome and in health.  Clin Endocrinol (Oxf). 1998;  48 (6) 733-737
    CrossrefPubMedGoogle Scholar
  • 8 Scott L V, Dinan T G. Urinary free cortisol excretion in chronic fatigue syndrome, major depression and in healthy volunteers.  J Affect Disord. 1998;  47 (1-3) 49-54
    CrossrefPubMedGoogle Scholar
  • 9 Scott L V, Teh J, Reznek R, Martin A, Sohaib A, Dinan T G. Small adrenal glands in chronic fatigue syndrome: a preliminary computer tomography study.  Psychoneuroendocrinology. 1999;  24 (7) 759-768
    CrossrefPubMedGoogle Scholar
  • 10 Cleare A J, Blair D, Chambers S, Wessely S. Urinary free cortisol in chronic fatigue syndrome.  Am J Psychiatry. 2001;  158 (4) 641-643
    CrossrefPubMedGoogle Scholar
  • 11 Demitrack M A, Gold P W, Dale J K, Krahn D D, Kling M A, Straus S E. Plasma and cerebrospinal fluid monoamine metabolism in patients with chronic fatigue syndrome: preliminary findings.  Biol Psychiatry. 1992;  32 (12) 1065-1077
    CrossrefPubMedGoogle Scholar
  • 12 Bakheit A MO, Behan P O, Dinan T G, Gray C E, O'Keane V. Possible upregulation of hypothalamic 5-hydroxytryptamine receptors in patients with postviral fatigue syndrome.  BMJ. 1992;  304 (6833) 1010-1012
    CrossrefPubMedGoogle Scholar
  • 13 Cleare A J, Bearn J, Allain T et al.. Contrasting neuroendocrine responses in depression and chronic fatigue syndrome.  J Affect Disord. 1995;  34 (4) 283-289
    CrossrefPubMedGoogle Scholar
  • 14 Moorkens G, Berwaerts J, Wynants H, Abs R. Characterization of pituitary function with emphasis on GH secretion in the chronic fatigue syndrome.  Clin Endocrinol (Oxf). 2000;  53 (1) 99-106
    CrossrefPubMedGoogle Scholar
  • 15 Patarca R. Cytokines and chronic fatigue syndrome.  Ann N Y Acad Sci. 2001;  933 185-200
    PubMedGoogle Scholar
  • 16 Gupta S, Aggarwal S, Starr A. Increased production of interleukin-6 by adherent and non-adherent mononuclear cells during ‘natural fatigue’ but not following ‘experimental fatigue' in patients with chronic fatigue syndrome.  Int J Mol Med. 1999;  3 (2) 209-213
    PubMedGoogle Scholar
  • 17 Gupta S, Aggarwal S, See D M, Starr A. Cytokine production by adherent and non-adherent mononuclear cells in chronic fatigue syndrome.  J Psychiatr Res. 1997;  31 (1) 149-156
    CrossrefPubMedGoogle Scholar
  • 18 Vgontzas A N, Zoumakis M, Papanicolaou D A et al.. Chronic insomnia is associated with a shift of interleukin-6 and tumor necrosis factor secretion from nighttime to daytime.  Metabolism. 2002;  51 (7) 887-892
    CrossrefPubMedGoogle Scholar
  • 19 Buchwald D, Cheney P R, Peterson D L et al.. A chronic illness characterized by fatigue, neurologic and immunologic disorders, and active human herpesvirus type 6 infection.  Ann Intern Med. 1992;  116 (2) 103-113
    PubMedGoogle Scholar
  • 20 Schwartz R B, Garada B M, Komaroff A L et al.. Detection of intracranial abnormalities in patients with chronic fatigue syndrome: comparison of MR imaging and SPECT.  AJR Am J Roentgenol. 1994;  162 (4) 935-941
    PubMedGoogle Scholar
  • 21 Natelson B H, Cohen J M, Brassloff I, Lee H J. A controlled study of brain magnetic resonance imaging in patients with the chronic fatigue syndrome.  J Neurol Sci. 1993;  120 (2) 213-217
    CrossrefPubMedGoogle Scholar
  • 22 Cook D B, Lange G, DeLuca J, Natelson B H. Relationship of brain MRI abnormalities and physical functional status in chronic fatigue syndrome.  Int J Neurosci. 2001;  107 (1-2) 1-6
    CrossrefPubMedGoogle Scholar
  • 23 Lange G, DeLuca J, Maldjian J A, Lee H-J, Tiersky L A, Natelson B H. Brain MRI abnormalities exist in a subset of patients with chronic fatigue syndrome.  J Neurol Sci. 1999;  171 (1) 3-7
    CrossrefPubMedGoogle Scholar
  • 24 Lange G, Holodny A I, DeLuca J et al.. Quantitative assessment of cerebral ventricular volumes in chronic fatigue syndrome.  Appl Neuropsychol. 2001;  8 (1) 23-30
    CrossrefPubMedGoogle Scholar
  • 25 Okada T, Tanaka M, Kuratsune H, Watanabe Y, Sadato N. Mechanisms underlying fatigue: a voxel-based morphometric study of chronic fatigue syndrome.  BMC Neurol. 2004;  4 14-19
    CrossrefPubMedGoogle Scholar
  • 26 de Lange F P, Kalkman J S, Bleijenberg G, Hagoort P, van der Meer J WM, Toni I. Gray matter volume reduction in the chronic fatigue syndrome.  Neuroimage. 2005;  26 (3) 777-781
    CrossrefPubMedGoogle Scholar
  • 27 Perrin R, Embleton K, Pentreath V W, Jackson A. Longitudinal MRI shows no cerebral abnormality in chronic fatigue syndrome.  Br J Radiol. 2010;  83 (989) 419-423
    CrossrefPubMedGoogle Scholar
  • 28 de Lange F P, Kalkman J S, Bleijenberg G et al.. Neural correlates of the chronic fatigue syndrome—an fMRI study.  Brain. 2004;  127 (Pt 9) 1948-1957
    CrossrefPubMedGoogle Scholar
  • 29 Tanaka M, Sadato N, Okada T et al.. Reduced responsiveness is an essential feature of chronic fatigue syndrome: A fMRI study.  BMC Neurol. 2006;  6 9-23
    CrossrefPubMedGoogle Scholar
  • 30 Caseras X, Mataix-Cols D, Giampietro V et al.. Probing the working memory system in chronic fatigue syndrome: a functional magnetic resonance imaging study using the n-back task.  Psychosom Med. 2006;  68 (6) 947-955
    CrossrefPubMedGoogle Scholar
  • 31 Cook D B, O'Connor P J, Lange G, Steffener J. Functional neuroimaging correlates of mental fatigue induced by cognition among chronic fatigue syndrome patients and controls.  Neuroimage. 2007;  36 (1) 108-122
    CrossrefPubMedGoogle Scholar
  • 32 Caseras X, Mataix-Cols D, Rimes K A et al.. The neural correlates of fatigue: an exploratory imaginal fatigue provocation study in chronic fatigue syndrome.  Psychol Med. 2008;  38 (7) 941-951
    PubMedGoogle Scholar
  • 33 Lange G, Steffener J, Cook D B et al.. Objective evidence of cognitive complaints in chronic fatigue syndrome: a BOLD fMRI study of verbal working memory.  Neuroimage. 2005;  26 (2) 513-524
    CrossrefPubMedGoogle Scholar
  • 34 Brooks J CW, Roberts N, Whitehouse G, Majeed T. Proton magnetic resonance spectroscopy and morphometry of the hippocampus in chronic fatigue syndrome.  Br J Radiol. 2000;  73 (875) 1206-1208
    PubMedGoogle Scholar
  • 35 Puri B K, Counsell S J, Zaman R et al.. Relative increase in choline in the occipital cortex in chronic fatigue syndrome.  Acta Psychiatr Scand. 2002;  106 (3) 224-226
    CrossrefPubMedGoogle Scholar
  • 36 Chaudhuri A, Condon B R, Gow J W, Brennan D, Hadley D M. Proton magnetic resonance spectroscopy of basal ganglia in chronic fatigue syndrome.  Neuroreport. 2003;  14 (2) 225-228
    CrossrefPubMedGoogle Scholar
  • 37 Ichise M, Salit I E, Abbey S E et al.. Assessment of regional cerebral perfusion by 99Tcm-HMPAO SPECT in chronic fatigue syndrome.  Nucl Med Commun. 1992;  13 (10) 767-772
    PubMedGoogle Scholar
  • 38 Schwartz R B, Komaroff A L, Garada B M et al.. SPECT imaging of the brain: comparison of findings in patients with chronic fatigue syndrome, AIDS dementia complex, and major unipolar depression.  AJR Am J Roentgenol. 1994;  162 (4) 943-951
    PubMedGoogle Scholar
  • 39 Schmaling K B, Lewis D H, Fiedelak J I, Mahurin R, Buchwald D S. Single-photon emission computerized tomography and neurocognitive function in patients with chronic fatigue syndrome.  Psychosom Med. 2003;  65 (1) 129-136
    CrossrefPubMedGoogle Scholar
  • 40 Fischler B, D'Haenen H, Cluydts R et al.. Comparison of 99m Tc HMPAO SPECT scan between chronic fatigue syndrome, major depression and healthy controls: an exploratory study of clinical correlates of regional cerebral blood flow.  Neuropsychobiology. 1996;  34 (4) 175-183
    CrossrefPubMedGoogle Scholar
  • 41 Lewis D H, Mayberg H S, Fischer M E et al.. Monozygotic twins discordant for chronic fatigue syndrome: regional cerebral blood flow SPECT.  Radiology. 2001;  219 (3) 766-773
    PubMedGoogle Scholar
  • 42 Siessmeier T, Nix W A, Hardt J, Schreckenberger M, Egle U T, Bartenstein P. Observer independent analysis of cerebral glucose metabolism in patients with chronic fatigue syndrome.  J Neurol Neurosurg Psychiatry. 2003;  74 (7) 922-928
    CrossrefPubMedGoogle Scholar
  • 43 Yamamoto S, Ouchi Y, Onoe H et al.. Reduction of serotonin transporters of patients with chronic fatigue syndrome.  Neuroreport. 2004;  15 (17) 2571-2574
    CrossrefPubMedGoogle Scholar
  • 44 Tirelli U, Chierichetti F, Tavio M et al.. Brain positron emission tomography (PET) in chronic fatigue syndrome: preliminary data.  Am J Med. 1998;  105 (3A) 54S-58S
    CrossrefPubMedGoogle Scholar
  • 45 Cleare A J, Messa C, Rabiner E A, Grasby P M. Brain 5-HT1A receptor binding in chronic fatigue syndrome measured using positron emission tomography and [11C]WAY-100635.  Biol Psychiatry. 2005;  57 (3) 239-246
    CrossrefPubMedGoogle Scholar
  • 46 Gordon R, Michalewski H J, Nguyen T, Gupta S, Starr A. Cortical motor potential alterations in chronic fatigue syndrome.  Int J Mol Med. 1999;  4 (5) 493-499
    PubMedGoogle Scholar
  • 47 Duffy F H, McAnulty G B, McCreary M C, Cuchural G J, Komaroff A L. EEG spectral coherence data distinguish chronic fatigue syndrome patients from healthy controls and depressed patients - A case control study.  BMC Neurol. 2011;  11 (1) 82
    CrossrefPubMedGoogle Scholar
  • 48 Siemionow V, Fang Y, Calabrese L, Sahgal V, Yue G H. Altered central nervous system signal during motor performance in chronic fatigue syndrome.  Clin Neurophysiol. 2004;  115 (10) 2372-2381
    CrossrefPubMedGoogle Scholar
  • 49 Natelson B H, Weaver S A, Tseng C-L, Ottenweller J E. Spinal fluid abnormalities in patients with chronic fatigue syndrome.  Clin Diagn Lab Immunol. 2005;  12 (1) 52-55
    PubMedGoogle Scholar
  • 50 Mathew S J, Mao X, Keegan K A et al.. Ventricular cerebrospinal fluid lactate is increased in chronic fatigue syndrome compared with generalized anxiety disorder: an in vivo 3.0 T (1)H MRS imaging study.  NMR Biomed. 2009;  22 (3) 251-258
    CrossrefPubMedGoogle Scholar
  • 51 Murrough J W, Mao X, Collins K A et al.. Increased ventricular lactate in chronic fatigue syndrome measured by 1H MRS imaging at 3.0 T. II: comparison with major depressive disorder.  NMR Biomed. 2010;  23 (6) 643-650
    CrossrefPubMedGoogle Scholar
  • 52 Baraniuk J N, Casado B, Maibach H, Clauw D J, Pannell L K, Hess S. A chronic fatigue syndrome-related proteome in human cerebrospinal fluid.  BMC Neurol. 2005;  5 22-40
    CrossrefPubMedGoogle Scholar
  • 53 Clauw D J. Perspectives on fatigue from the study of chronic fatigue syndrome and related conditions.  PM R. 2010;  2 (5) 414-430
    CrossrefPubMedGoogle Scholar
  • 54 Johnson S K, DeLuca J, Fiedler N, Natelson B H. Cognitive functioning of patients with chronic fatigue syndrome.  Clin Infect Dis. 1994;  18 (Suppl 1) S84-S85
    CrossrefPubMedGoogle Scholar
  • 55 Krupp L B, Sliwinski M, Masur D M, Friedberg F, Coyle P K. Cognitive functioning and depression in patients with chronic fatigue syndrome and multiple sclerosis.  Arch Neurol. 1994;  51 (7) 705-710
    CrossrefPubMedGoogle Scholar
  • 56 Marcel B, Komaroff A L, Fagioli L R, Kornish II R J, Albert M S. Cognitive deficits in patients with chronic fatigue syndrome.  Biol Psychiatry. 1996;  40 (6) 535-541
    CrossrefPubMedGoogle Scholar
  • 57 Tiersky L A, Johnson S K, Lange G, Natelson B H, DeLuca J. Neuropsychology of chronic fatigue syndrome: a critical review.  J Clin Exp Neuropsychol. 1997;  19 (4) 560-586
    CrossrefPubMedGoogle Scholar
  • 58 Daly E, Komaroff A L, Bloomingdale K, Wilson S, Albert M S. Neuropsychological function in patients with chronic fatigue syndrome, multiple sclerosis, and depression.  Appl Neuropsychol. 2001;  8 (1) 12-22
    CrossrefPubMedGoogle Scholar
  • 59 Deluca J, Christodoulou C, Diamond B J, Rosenstein E D, Kramer N, Natelson B H. Working memory deficits in chronic fatigue syndrome: differentiating between speed and accuracy of information processing.  J Int Neuropsychol Soc. 2004;  10 (1) 101-109
    PubMedGoogle Scholar
  • 60 DeLuca J, Johnson S K, Natelson B H. Information processing efficiency in chronic fatigue syndrome and multiple sclerosis.  Arch Neurol. 1993;  50 (3) 301-304
    CrossrefPubMedGoogle Scholar
  • 61 Sandman C A, Barron J L, Nackoul K, Goldstein J, Fidler F. Memory deficits associated with chronic fatigue immune dysfunction syndrome.  Biol Psychiatry. 1993;  33 (8-9) 618-623
    CrossrefPubMedGoogle Scholar
  • 62 McDonald E, Cope H, David A. Cognitive impairment in patients with chronic fatigue: a preliminary study.  J Neurol Neurosurg Psychiatry. 1993;  56 (7) 812-815
    CrossrefPubMedGoogle Scholar
  • 63 DeLuca J, Johnson S K, Natelson B H. Information processing efficiency in chronic fatigue syndrome and multiple sclerosis.  Arch Neurol. 1993;  50 (3) 301-304
    CrossrefPubMedGoogle Scholar
  • 64 Schmaling K B, DiClementi J D, Cullum C M, Jones J F. Cognitive functioning in chronic fatigue syndrome and depression: a preliminary comparison.  Psychosom Med. 1994;  56 (5) 383-388
    PubMedGoogle Scholar
  • 65 DeLuca J, Johnson S K, Beldowicz D, Natelson B H. Neuropsychological impairments in chronic fatigue syndrome, multiple sclerosis, and depression.  J Neurol Neurosurg Psychiatry. 1995;  58 (1) 38-43
    CrossrefPubMedGoogle Scholar
  • 66 DeLuca J, Johnson S K, Ellis S P, Natelson B H. Cognitive functioning is impaired in patients with chronic fatigue syndrome devoid of psychiatric disease.  J Neurol Neurosurg Psychiatry. 1997;  62 (2) 151-155
    CrossrefPubMedGoogle Scholar
  • 67 Michiels V, Cluydts R, Fischler B. Attention and verbal learning in patients with chronic fatigue syndrome.  J Int Neuropsychol Soc. 1998;  4 (5) 456-466
    CrossrefPubMedGoogle Scholar
  • 68 Cockshell S J, Mathias J L. Cognitive functioning in chronic fatigue syndrome: a meta-analysis.  Psychol Med. 2010;  40 (8) 1253-1267
    CrossrefPubMedGoogle Scholar
  • 69 Constant E L, Adam S, Gillain B, Lambert M, Masquelier E, Seron X. Cognitive deficits in patients with chronic fatigue syndrome compared to those with major depressive disorder and healthy controls.  Clin Neurol Neurosurg. 2011;  113 (4) 295-302
    CrossrefPubMedGoogle Scholar
  • 70 Sisto S A, Tapp W, Drastal S et al.. Vagal tone is reduced during paced breathing in patients with the chronic fatigue syndrome.  Clin Auton Res. 1995;  5 (3) 139-143
    CrossrefPubMedGoogle Scholar
  • 71 Bou-Holaigah I, Rowe P C, Kan J, Calkins H. The relationship between neurally mediated hypotension and the chronic fatigue syndrome.  JAMA. 1995;  274 (12) 961-967
    CrossrefPubMedGoogle Scholar
  • 72 Freeman R, Komaroff A L. Does the chronic fatigue syndrome involve the autonomic nervous system?.  Am J Med. 1997;  102 (4) 357-364
    CrossrefPubMedGoogle Scholar
  • 73 Stewart J M, Gewitz M H, Weldon A, Arlievsky N, Li K, Munoz J. Orthostatic intolerance in adolescent chronic fatigue syndrome.  Pediatrics. 1999;  103 (1) 116-121
    CrossrefPubMedGoogle Scholar
  • 74 Stewart J M. Autonomic nervous system dysfunction in adolescents with postural orthostatic tachycardia syndrome and chronic fatigue syndrome is characterized by attenuated vagal baroreflex and potentiated sympathetic vasomotion.  Pediatr Res. 2000;  48 (2) 218-226
    CrossrefPubMedGoogle Scholar
  • 75 Naschitz J E, Sabo E, Naschitz S et al.. Hemodynamic instability in chronic fatigue syndrome: indices and diagnostic significance.  Semin Arthritis Rheum. 2001;  31 (3) 199-208
    CrossrefPubMedGoogle Scholar
  • 76 Naschitz J E, Sabo E, Naschitz S et al.. Fractal analysis and recurrence quantification analysis of heart rate and pulse transit time for diagnosing chronic fatigue syndrome.  Clin Auton Res. 2002;  12 (4) 264-272
    CrossrefPubMedGoogle Scholar
  • 77 Peckerman A, LaManca J J, Qureishi B et al.. Baroreceptor reflex and integrative stress responses in chronic fatigue syndrome.  Psychosom Med. 2003;  65 (5) 889-895
    CrossrefPubMedGoogle Scholar
  • 78 Jones J F, Nicholson A, Nisenbaum R et al.. Orthostatic instability in a population-based study of chronic fatigue syndrome.  Am J Med. 2005;  118 (12) 1415
    PubMedGoogle Scholar
  • 79 Hollingsworth K G, Jones D E, Taylor R, Blamire A M, Newton J L. Impaired cardiovascular response to standing in chronic fatigue syndrome.  Eur J Clin Invest. 2010;  40 (7) 608-615
    CrossrefPubMedGoogle Scholar
  • 80 Biswal B, Kunwar P, Natelson B H. Cerebral blood flow is reduced in chronic fatigue syndrome as assessed by arterial spin labeling.  J Neurol Sci. 2011;  301 (1-2) 9-11
    CrossrefPubMedGoogle Scholar
  • 81 Gerrity T R, Bates J, Bell D S et al.. Chronic fatigue syndrome: what role does the autonomic nervous system play in the pathophysiology of this complex illness?.  Neuroimmunomodulation. 2002-2003;  10 (3) 134-141
    CrossrefPubMedGoogle Scholar
  • 82 Newton J L, Okonkwo O, Sutcliffe K, Seth A, Shin J, Jones D EJ. Symptoms of autonomic dysfunction in chronic fatigue syndrome.  QJM. 2007;  100 (8) 519-526
    CrossrefPubMedGoogle Scholar
  • 83 Taerk G S, Toner B B, Salit I E, Garfinkel P E, Ozersky S. Depression in patients with neuromyasthenia (benign myalgic encephalomyelitis).  Int J Psychiatry Med. 1987;  17 (1) 49-56
    CrossrefPubMedGoogle Scholar
  • 84 Kruesi M JP, Dale J, Straus S E. Psychiatric diagnoses in patients who have chronic fatigue syndrome.  J Clin Psychiatry. 1989;  50 (2) 53-56
    PubMedGoogle Scholar
  • 85 Wessely S, Powell R. Fatigue syndromes: a comparison of chronic “postviral” fatigue with neuromuscular and affective disorders.  J Neurol Neurosurg Psychiatry. 1989;  52 (8) 940-948
    CrossrefPubMedGoogle Scholar
  • 86 Hickie I, Lloyd A, Wakefield D, Parker G. The psychiatric status of patients with the chronic fatigue syndrome.  Br J Psychiatry. 1990;  156 534-540
    CrossrefPubMedGoogle Scholar
  • 87 Gold D, Bowden R, Sixbey J et al.. Chronic fatigue. A prospective clinical and virologic study.  JAMA. 1990;  264 (1) 48-53
    CrossrefPubMedGoogle Scholar
  • 88 Vercoulen JHMM, Swanink C MA, Zitman F G et al.. Randomised, double-blind, placebo-controlled study of fluoxetine in chronic fatigue syndrome.  Lancet. 1996;  347 (9005) 858-861
    CrossrefPubMedGoogle Scholar
  • 89 Benjamin J E, Hoyt R C. Disability following postvaccinal (yellow fever) hepatitis.  JAMA. 1945;  128 319-324
    CrossrefPubMedGoogle Scholar
  • 90 Imboden J B, Canter A, Cluff L E. Convalescence from influenza. A study of the psychological and clinical determinants.  Arch Intern Med. 1961;  108 393-399
    CrossrefPubMedGoogle Scholar
  • 91 Lawton A H, Rich T A, McLendon S, Gates E H, Bond J O. Follow-up studies of St. Louis encephalitis in Florida: reevaluation of the emotional and health status of the survivors five years after acute illness.  South Med J. 1970;  63 (1) 66-71
    CrossrefPubMedGoogle Scholar
  • 92 Rosene K A, Copass M K, Kastner L S, Nolan C M, Eschenbach D A. Persistent neuropsychological sequelae of toxic shock syndrome.  Ann Intern Med. 1982;  96 (6 Pt 2) 865-870
    CrossrefPubMedGoogle Scholar
  • 93 Cluff L E, Trever R W, Imboden J B, Canter A. Brucellosis. II. Medical aspects of delayed convalescence.  AMA Arch Intern Med. 1959;  103 (3) 398-405
    CrossrefPubMedGoogle Scholar
  • 94 Imboden J B, Canter A, Cluff L E, Trever R W. Brucellosis. III. Psychologic aspects of delayed convalescence.  AMA Arch Intern Med. 1959;  103 (3) 406-414
    CrossrefPubMedGoogle Scholar
  • 95 Salit I E. Sporadic postinfectious neuromyasthenia.  CMAJ. 1985;  133 (7) 659-663
    PubMedGoogle Scholar
  • 96 Henderson D A, Shelokov A. Epidemic neuromyasthenia; clinical syndrome.  N Engl J Med. 1959;  260 (15) 757-764
    CrossrefPubMedGoogle Scholar
  • 97 Hickie I, Davenport T, Wakefield D Dubbo Infection Outcomes Study Group et al. Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study.  BMJ. 2006;  333 (7568) 575-578
    CrossrefPubMedGoogle Scholar
  • 98 Vollmer-Conna U, Fazou C, Cameron B et al.. Production of pro-inflammatory cytokines correlates with the symptoms of acute sickness behaviour in humans.  Psychol Med. 2004;  34 (7) 1289-1297
    CrossrefPubMedGoogle Scholar
  • 99 Cameron B, Bharadwaj M, Burrows J Dubbo Infection Outcomes Study et al. Prolonged illness after infectious mononucleosis is associated with altered immunity but not with increased viral load.  J Infect Dis. 2006;  193 (5) 664-671
    CrossrefPubMedGoogle Scholar
  • 100 Vollmer-Conna U, Cameron B, Hadzi-Pavlovic D Dubbo Infective Outcomes Study Group et al. Postinfective fatigue syndrome is not associated with altered cytokine production.  Clin Infect Dis. 2007;  45 (6) 732-735
    CrossrefPubMedGoogle Scholar
  • 101 Landay A L, Jessop C, Lennette E T, Levy J A. Chronic fatigue syndrome: clinical condition associated with immune activation.  Lancet. 1991;  338 (8769) 707-712
    CrossrefPubMedGoogle Scholar
  • 102 Patarca R, Klimas N G, Lugtendorf S, Antoni M, Fletcher M A. Dysregulated expression of tumor necrosis factor in chronic fatigue syndrome: interrelations with cellular sources and patterns of soluble immune mediator expression.  Clin Infect Dis. 1994;  18 (Suppl 1) S147-S153
    CrossrefPubMedGoogle Scholar
  • 103 Cannon J G, Angel J, Abad L et al.. Interleukin-1b, interleukin-1 receptor antagonist and soluble interleukin-1 receptor type II secretion in chronic fatigue syndrome.  J Clin Immunol. 1997;  17 (3) 253-261
    CrossrefPubMedGoogle Scholar
  • 104 Swanink C M, Vercoulen J H, Galama J M et al.. Lymphocyte subsets, apoptosis, and cytokines in patients with chronic fatigue syndrome.  J Infect Dis. 1996;  173 (2) 460-463
    CrossrefPubMedGoogle Scholar
  • 105 Bennett A L, Chao C C, Hu S et al.. Elevation of bioactive transforming growth factor-beta in serum from patients with chronic fatigue syndrome.  J Clin Immunol. 1997;  17 (2) 160-166
    CrossrefPubMedGoogle Scholar
  • 106 Cannon J G, Angel J B, Ball R W, Abad L W, Fagioli L, Komaroff A L. Acute phase responses and cytokine secretion in chronic fatigue syndrome.  J Clin Immunol. 1999;  19 (6) 414-421
    CrossrefPubMedGoogle Scholar
  • 107 Skowera A, Cleare A, Blair D, Bevis L, Wessely S C, Peakman M. High levels of type 2 cytokine-producing cells in chronic fatigue syndrome.  Clin Exp Immunol. 2004;  135 (2) 294-302
    CrossrefPubMedGoogle Scholar
  • 108 Broderick G, Fuite J, Kreitz A, Vernon S D, Klimas N, Fletcher M A. A formal analysis of cytokine networks in chronic fatigue syndrome.  Brain Behav Immun. 2010;  24 (7) 1209-1217
    CrossrefPubMedGoogle Scholar
  • 109 Caligiuri M, Murray C, Buchwald D et al.. Phenotypic and functional deficiency of natural killer cells in patients with chronic fatigue syndrome.  J Immunol. 1987;  139 (10) 3306-3313
    PubMedGoogle Scholar
  • 110 Aoki T, Usuda Y, Miyakoshi H, Tamura K, Herberman R B. Low natural killer syndrome: clinical and immunologic features.  Nat Immun Cell Growth Regul. 1987;  6 (3) 116-128
    PubMedGoogle Scholar
  • 111 Kibler R, Lucas D O, Hicks M J, Poulos B T, Jones J F. Immune function in chronic active Epstein-Barr virus infection.  J Clin Immunol. 1985;  5 (1) 46-54
    CrossrefPubMedGoogle Scholar
  • 112 Klimas N G, Salvato F R, Morgan R, Fletcher M A. Immunologic abnormalities in chronic fatigue syndrome.  J Clin Microbiol. 1990;  28 (6) 1403-1410
    PubMedGoogle Scholar
  • 113 Whiteside T L, Herberman R B. The role of natural killer cells in human disease.  Clin Immunol Immunopathol. 1989;  53 (1) 1-23
    CrossrefPubMedGoogle Scholar
  • 114 Suhadolnik R J, Reichenbach N L, Hitzges P et al.. Upregulation of the 2-5A synthetase/RNase L antiviral pathway associated with chronic fatigue syndrome.  Clin Infect Dis. 1994;  18 (Suppl 1) S96-S104
    CrossrefPubMedGoogle Scholar
  • 115 Suhadolnik R J, Peterson D L, O'Brien K et al.. Biochemical evidence for a novel low molecular weight 2-5A-dependent RNase L in chronic fatigue syndrome.  J Interferon Cytokine Res. 1997;  17 (7) 377-385
    CrossrefPubMedGoogle Scholar
  • 116 De Meirleir K, Bisbal C, Campine I et al.. A 37 kDa 2-5A binding protein as a potential biochemical marker for chronic fatigue syndrome.  Am J Med. 2000;  108 (2) 99-105
    PubMedGoogle Scholar
  • 117 Vernon S D, Unger E R, Dimulescu I M, Rajeevan M, Reeves W C. Utility of the blood for gene expression profiling and biomarker discovery in chronic fatigue syndrome.  Dis Markers. 2002;  18 (4) 193-199
    PubMedGoogle Scholar
  • 118 Powell R, Ren J, Lewith G, Barclay W, Holgate S, Almond J. Identification of novel expressed sequences, up-regulated in the leucocytes of chronic fatigue syndrome patients.  Clin Exp Allergy. 2003;  33 (10) 1450-1456
    CrossrefPubMedGoogle Scholar
  • 119 Steinau M, Unger E R, Vernon S D, Jones J F, Rajeevan M S. Differential-display PCR of peripheral blood for biomarker discovery in chronic fatigue syndrome.  J Mol Med (Berl). 2004;  82 (11) 750-755
    CrossrefPubMedGoogle Scholar
  • 120 Kaushik N, Fear D, Richards S CM et al.. Gene expression in peripheral blood mononuclear cells from patients with chronic fatigue syndrome.  J Clin Pathol. 2005;  58 (8) 826-832
    CrossrefPubMedGoogle Scholar
  • 121 Vernon S D, Whistler T, Aslakson E, Rajeevan M, Reeves W C. Challenges for molecular profiling of chronic fatigue syndrome.  Pharmacogenomics. 2006;  7 (2) 211-218
    CrossrefPubMedGoogle Scholar
  • 122 Gow J W, Hagan S, Herzyk P, Cannon C, Behan P O, Chaudhuri A. A gene signature for post-infectious chronic fatigue syndrome.  BMC Med Genomics. 2009;  2 38
    CrossrefPubMedGoogle Scholar
  • 123 Kuratsune H, Yamaguti K, Takahashi M, Misaki H, Tagawa S, Kitani T. Acylcarnitine deficiency in chronic fatigue syndrome.  Clin Infect Dis. 1994;  18 (Suppl 1) S62-S67
    CrossrefPubMedGoogle Scholar
  • 124 Plioplys A V, Plioplys S. Electron-microscopic investigation of muscle mitochondria in chronic fatigue syndrome.  Neuropsychobiology. 1995;  32 (4) 175-181
    CrossrefPubMedGoogle Scholar
  • 125 Edwards R HT, Gibson H, Clague J E, Helliwell T. Muscle histopathology and physiology in chronic fatigue syndrome. In: Bock G R, Whelan J, eds. Chronic Fatigue Syndrome. New York: Wiley; 1993: 102-131
    Google Scholar
  • 126 Pietrangelo T, Mancinelli R, Toniolo L et al.. Transcription profile analysis of vastus lateralis muscle from patients with chronic fatigue syndrome.  Int J Immunopathol Pharmacol. 2009;  22 (3) 795-807
    PubMedGoogle Scholar
  • 127 Vernon S D, Whistler T, Cameron B, Hickie I B, Reeves W C, Lloyd A. Preliminary evidence of mitochondrial dysfunction associated with post-infective fatigue after acute infection with Epstein Barr Virus.  BMC Infect Dis. 2006;  6 15-21
    CrossrefPubMedGoogle Scholar
  • 128 Robinson M, Gray S R, Watson M S et al.. Plasma IL-6, its soluble receptors and F2-isoprostanes at rest and during exercise in chronic fatigue syndrome.  Scand J Med Sci Sports. 2010;  20 (2) 282-290
    PubMedGoogle Scholar
  • 129 Manuel y Keenoy B, Moorkens G, Vertommen J, De Leeuw I. Antioxidant status and lipoprotein peroxidation in chronic fatigue syndrome.  Life Sci. 2001;  68 (17) 2037-2049
    CrossrefPubMedGoogle Scholar
  • 130 Pall M L. Elevated, sustained peroxynitrite levels as the cause of chronic fatigue syndrome.  Med Hypotheses. 2000;  54 (1) 115-125
    CrossrefPubMedGoogle Scholar
  • 131 Miwa K, Fujita M. Increased oxidative stress suggested by low serum vitamin E concentrations in patients with chronic fatigue syndrome.  Int J Cardiol. 2009;  136 (2) 238-239
    CrossrefPubMedGoogle Scholar
  • 132 Puri B K, Agour M, Gunatilake K DR, Fernando K AC, Gurusinghe A I, Treasaden I H. An in vivo proton neurospectroscopy study of cerebral oxidative stress in myalgic encephalomyelitis (chronic fatigue syndrome).  Prostaglandins Leukot Essent Fatty Acids. 2009;  81 (5-6) 303-305
    CrossrefPubMedGoogle Scholar
  • 133 Miwa K, Fujita M. Fluctuation of serum vitamin E (alpha-tocopherol) concentrations during exacerbation and remission phases in patients with chronic fatigue syndrome.  Heart Vessels. 2010;  25 (4) 319-323
    CrossrefPubMedGoogle Scholar
  • 134 Pall M L, Satterlee J D. Elevated nitric oxide/peroxynitrite mechanism for the common etiology of multiple chemical sensitivity, chronic fatigue syndrome, and posttraumatic stress disorder.  Ann N Y Acad Sci. 2001;  933 323-329
    PubMedGoogle Scholar
  • 135 Maes M, Mihaylova I, Kubera M, Bosmans E. Not in the mind but in the cell: increased production of cyclo-oxygenase-2 and inducible NO synthase in chronic fatigue syndrome.  Neuroendocrinol Lett. 2007;  28 (4) 463-469
    PubMedGoogle Scholar
  • 136 Maes M, Mihaylova I, Bosmans E. Not in the mind of neurasthenic lazybones but in the cell nucleus: patients with chronic fatigue syndrome have increased production of nuclear factor kappa beta.  Neuroendocrinol Lett. 2007;  28 (4) 456-462
    PubMedGoogle Scholar
  • 137 Suárez A, Guillamó E, Roig T et al.. Nitric oxide metabolite production during exercise in chronic fatigue syndrome: a case-control study.  J Womens Health (Larchmt). 2010;  19 (6) 1073-1077
    CrossrefPubMedGoogle Scholar
  • 138 Light A R, White A T, Hughen R W, Light K C. Moderate exercise increases expression for sensory, adrenergic, and immune genes in chronic fatigue syndrome patients but not in normal subjects.  J Pain. 2009;  10 (10) 1099-1112
    CrossrefPubMedGoogle Scholar
  • 139 Van Oosterwijck J, Nijs J, Meeus M et al.. Pain inhibition and postexertional malaise in myalgic encephalomyelitis/chronic fatigue syndrome: an experimental study.  J Intern Med. 2010;  268 (3) 265-278
    CrossrefPubMedGoogle Scholar
  • 140 Manfredi A A, Rovere-Querini P. The mitochondrion—a Trojan horse that kicks off inflammation?.  N Engl J Med. 2010;  362 (22) 2132-2134
    CrossrefPubMedGoogle Scholar
  • 141 Valyi-Nagy T, Dermody T S. Role of oxidative damage in the pathogenesis of viral infections of the nervous system.  Histol Histopathol. 2005;  20 (3) 957-967
    PubMedGoogle Scholar
  • 142 Isaacs R. Chronic infectious mononucleosis.  Blood. 1948;  3 (8) 858-861
    PubMedGoogle Scholar
  • 143 White P D, Thomas J M, Amess J et al.. Incidence, risk and prognosis of acute and chronic fatigue syndromes and psychiatric disorders after glandular fever.  Br J Psychiatry. 1998;  173 475-481
    CrossrefPubMedGoogle Scholar
  • 144 Katon W, Russo J, Ashley R L, Buchwald D. Infectious mononucleosis: psychological symptoms during acute and subacute phases of illness.  Gen Hosp Psychiatry. 1999;  21 (1) 21-29
    CrossrefPubMedGoogle Scholar
  • 145 Jones J F, Ray C G, Minnich L L, Hicks M J, Kibler R, Lucas D O. Evidence for active Epstein-Barr virus infection in patients with persistent, unexplained illnesses: elevated anti-early antigen antibodies.  Ann Intern Med. 1985;  102 (1) 1-7
    PubMedGoogle Scholar
  • 146 Straus S E, Tosato G, Armstrong G et al.. Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection.  Ann Intern Med. 1985;  102 (1) 7-16
    PubMedGoogle Scholar
  • 147 Salahuddin S Z, Ablashi D V, Markham P D et al.. Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders.  Science. 1986;  234 (4776) 596-601
    CrossrefPubMedGoogle Scholar
  • 148 Josephs S F, Henry B, Balachandran N et al.. HHV-6 reactivation in chronic fatigue syndrome.  Lancet. 1991;  337 (8753) 1346-1347
    CrossrefPubMedGoogle Scholar
  • 149 Secchiero P, Carrigan D R, Asano Y et al.. Detection of human herpesvirus 6 in plasma of children with primary infection and immunosuppressed patients by polymerase chain reaction.  J Infect Dis. 1995;  171 (2) 273-280
    CrossrefPubMedGoogle Scholar
  • 150 Zorenzenon M, Rukh G, Botta G A et al.. Active HHV-6 infection in chronic fatigue syndrome patients from Italy: New data.  J Chron Fatigue Syndr. 1996;  2 3-12
    PubMedGoogle Scholar
  • 151 Patnaik M, Komaroff A L, Conley E, Ojo-Amaize E A, Peter J B. Prevalence of IgM antibodies to human herpesvirus 6 early antigen (p41/38) in patients with chronic fatigue syndrome.  J Infect Dis. 1995;  172 (5) 1364-1367
    CrossrefPubMedGoogle Scholar
  • 152 Wagner M, Krueger G RF, Ablashi D V, Whitman J E. Chronic fatigue syndrome (CFS): a critical evaluation of testing for active human herpesvirus-6 (HHV-6) infection: review of data of 107 cases.  J Chron Fatigue Syndr. 1996;  2 3-16
    PubMedGoogle Scholar
  • 153 Ablashi D V, Eastman H B, Owen C B et al.. Frequent HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patients.  J Clin Virol. 2000;  16 (3) 179-191
    CrossrefPubMedGoogle Scholar
  • 154 Nicolson G L, Gan R, Haier J. Multiple co-infections (mycoplasma, chlamydia, human herpes virus-6) in blood of chronic fatigue syndrome patients: association with signs and symptoms.  APMIS. 2003;  111 (5) 557-566
    CrossrefPubMedGoogle Scholar
  • 155 Koelle D M, Barcy S, Huang M L et al.. Markers of viral infection in monozygotic twins discordant for chronic fatigue syndrome.  Clin Infect Dis. 2002;  35 (5) 518-525
    CrossrefPubMedGoogle Scholar
  • 156 Reeves W C, Stamey F R, Black J B, Mawle A C, Stewart J A, Pellett P E. Human herpesviruses 6 and 7 in chronic fatigue syndrome: a case-control study.  Clin Infect Dis. 2000;  31 (1) 48-52
    CrossrefPubMedGoogle Scholar
  • 157 Yao K, Crawford J R, Komaroff A L, Ablashi D V, Jacobson S. Review part 2: Human herpesvirus-6 in central nervous system diseases.  J Med Virol. 2010;  82 (10) 1669-1678
    CrossrefPubMedGoogle Scholar
  • 158 Flamand L, Gosselin J, D'Addario M et al.. Human herpesvirus 6 induces interleukin-1 beta and tumor necrosis factor alpha, but not interleukin-6, in peripheral blood mononuclear cell cultures.  J Virol. 1991;  65 (9) 5105-5110
    PubMedGoogle Scholar
  • 159 Enoki H, Takeda S, Matsubayashi R, Matsubayashi T. Steroid therapy in an infant with human herpesvirus 6 encephalopathy.  Brain Dev. 2006;  28 (9) 597-599
    CrossrefPubMedGoogle Scholar
  • 160 Krueger G R, Guenther A, Knuefermann R et al.. Human herpesvirus-6 (HHV-6) in Hodgkin's disease: cellular expression of viral antigens as compared to oncogenes met and fes, tumor suppressor gene product p53, and interleukins 2 and 6.  In Vivo. 1994;  8 (4) 501-516
    PubMedGoogle Scholar
  • 161 Arena A, Capozza A B, Di Luca D. Role of IFN gamma on TNF alpha, IL-1 beta and IL-6 release during HHV-6 infection.  New Microbiol. 1996;  19 (3) 183-191
    PubMedGoogle Scholar
  • 162 Go T, Nakamura K. Frequent seizures with elevated interleukin-6 at the eruptive stage of exanthema subitum.  Eur J Paediatr Neurol. 2002;  6 (4) 221-223
    CrossrefPubMedGoogle Scholar
  • 163 Silverman R H, Nguyen C, Weight C J, Klein E A. The human retrovirus XMRV in prostate cancer and chronic fatigue syndrome.  Nat Rev Urol. 2010;  7 (7) 392-402
    CrossrefPubMedGoogle Scholar
  • 164 Lombardi V C, Ruscetti F W, Das Gupta J et al.. Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome.  Science. 2009;  326 (5952) 585-589
    CrossrefPubMedGoogle Scholar
  • 165 Lo S-C, Pripuzova N, Li B et al.. Detection of MLV-related virus gene sequences in blood of patients with chronic fatigue syndrome and healthy blood donors.  Proc Natl Acad Sci U S A. 2010;  107 (36) 15874-15879
    CrossrefPubMedGoogle Scholar
  • 166 Henrich T J, Li J Z, Felsenstein D et al.. Xenotropic murine leukemia virus-related virus prevalence in patients with chronic fatigue syndrome or chronic immunomodulatory conditions.  J Infect Dis. 2010;  202 (10) 1478-1481
    CrossrefPubMedGoogle Scholar
  • 167 Knox K, Carrigan D, Simmons G et al.. No evidence of murine-like gammaretroviruses in CFS patients previously identified as XMRV-infected.  Science. 2011;  333 (6038) 94-97
    CrossrefPubMedGoogle Scholar
  • 168 Shin C H, Bateman L, Schlaberg R et al.. Absence of XMRV and other MLV-related viruses in patients with chronic fatigue syndrome.  J Virol. 2011;  85 7195-7202
    CrossrefPubMedGoogle Scholar
  • 169 Cunningham L, Bowles N E, Lane R JM, Dubowitz V, Archard L C. Persistence of enteroviral RNA in chronic fatigue syndrome is associated with the abnormal production of equal amounts of positive and negative strands of enteroviral RNA.  J Gen Virol. 1990;  71 (Pt 6) 1399-1402
    CrossrefPubMedGoogle Scholar
  • 170 Gow J W, Behan W MH, Clements G B, Woodall C, Riding M, Behan P O. Enteroviral RNA sequences detected by polymerase chain reaction in muscle of patients with postviral fatigue syndrome.  BMJ. 1991;  302 (6778) 692-696
    CrossrefPubMedGoogle Scholar
  • 171 Bowles N E, Bayston T A, Zhang H Y et al.. Persistence of enterovirus RNA in muscle biopsy samples suggests that some cases of chronic fatigue syndrome result from a previous, inflammatory viral myopathy.  J Med. 1993;  24 (2-3) 145-160
    PubMedGoogle Scholar
  • 172 Clements G B, McGarry F, Nairn C, Galbraith D N. Detection of enterovirus-specific RNA in serum: the relationship to chronic fatigue.  J Med Virol. 1995;  45 (2) 156-161
    CrossrefPubMedGoogle Scholar
  • 173 Richardson J. Disturbance of hypothalamic function and evidence for persistent enteroviral infection in patients with chronic fatigue syndrome.  J Chron Fatigue Syndr. 1995;  1 59-66
    PubMedGoogle Scholar
  • 174 Soteriou B, Zhang H, Woodrow D R, Lane R JM, Archard L C. Identification of enteroviral RNA detected in muscle biopsies from patients with chronic fatigue syndrome of myositis, using reverse transcription-nested polymerase chain reaction and nucleotide sequencing.  J Chron Fatigue Syndr. 1996;  2 74-75
    PubMedGoogle Scholar
  • 175 Gow J W, Behan W MH, Cash P et al.. Enteroviral replication and chronic fatigue syndrome.  J Chron Fatigue Syndr. 1996;  2 86
    PubMedGoogle Scholar
  • 176 Chia J KS, Chia A Y. Chronic fatigue syndrome is associated with chronic enterovirus infection of the stomach.  J Clin Pathol. 2008;  61 (1) 43-48
    PubMedGoogle Scholar
  • 177 Swanink C MA, Melchers W JG, van der Meer J WM et al.. Enteroviruses and the chronic fatigue syndrome.  Clin Infect Dis. 1994;  19 (5) 860-864
    CrossrefPubMedGoogle Scholar
  • 178 Lindh G, Samuelson A, Hedlund K O, Evengård B, Lindquist L, Ehrnst A. No findings of enteroviruses in Swedish patients with chronic fatigue syndrome.  Scand J Infect Dis. 1996;  28 (3) 305-307
    CrossrefPubMedGoogle Scholar
  • 179 Kerr J R, Bracewell J, Laing I et al.. Chronic fatigue syndrome and arthralgia following parvovirus B19 infection.  J Rheumatol. 2002;  29 (3) 595-602
    PubMedGoogle Scholar
  • 180 Kerr J R, Barah F, Mattey D L et al.. Circulating tumour necrosis factor-alpha and interferon-gamma are detectable during acute and convalescent parvovirus B19 infection and are associated with prolonged and chronic fatigue.  J Gen Virol. 2001;  82 (Pt 12) 3011-3019
    PubMedGoogle Scholar
  • 181 Matano S, Kinoshita H, Tanigawa K, Terahata S, Sugimoto T. Acute parvovirus B19 infection mimicking chronic fatigue syndrome.  Intern Med. 2003;  42 (9) 903-905
    CrossrefPubMedGoogle Scholar
  • 182 Kerr J R, Gough J, Richards S CM et al.. Antibody to parvovirus B19 nonstructural protein is associated with chronic arthralgia in patients with chronic fatigue syndrome/myalgic encephalomyelitis.  J Gen Virol. 2010;  91 (Pt 4) 893-897
    CrossrefPubMedGoogle Scholar
  • 183 Coyle P K, Krupp L. Borrelia burgdorferi infection in the chronic fatigue syndrome.  Ann Neurol. 1990;  28 243-244
    PubMedGoogle Scholar
  • 184 Sigal L H. Summary of the first 100 patients seen at a Lyme disease referral center.  Am J Med. 1990;  88 (6) 577-581
    CrossrefPubMedGoogle Scholar
  • 185 Pollark R J, Komaroff A L, Telford III S R et al.. Borrelia burgdorferi infection is rarely found in patients with chronic fatigue syndrome.  Clin Infect Dis. 1995;  20 (2) 467-468
    CrossrefPubMedGoogle Scholar
  • 186 Wildman M J, Smith E G, Groves J, Beattie J M, Caul E O, Ayres J G. Chronic fatigue following infection by Coxiella burnetii (Q fever): ten-year follow-up of the 1989 UK outbreak cohort.  QJM. 2002;  95 (8) 527-538
    CrossrefPubMedGoogle Scholar
  • 187 Marmion B P, Sukocheva O, Storm P A et al.. Q fever: persistence of antigenic non-viable cell residues of Coxiella burnetii in the host—implications for post Q fever infection fatigue syndrome and other chronic sequelae.  QJM. 2009;  102 (10) 673-684
    CrossrefPubMedGoogle Scholar
  • 188 Penttila I A, Harris R J, Storm P, Haynes D, Worswick D A, Marmion B P. Cytokine dysregulation in the post-Q-fever fatigue syndrome.  QJM. 1998;  91 (8) 549-560
    CrossrefPubMedGoogle Scholar
  • 189 Schluederberg A, Straus S E, Peterson P et al.. NIH conference. Chronic fatigue syndrome research. Definition and medical outcome assessment.  Ann Intern Med. 1992;  117 (4) 325-331
    PubMedGoogle Scholar
  • 190 Bates D W, Buchwald D, Lee J et al.. Clinical laboratory test findings in patients with chronic fatigue syndrome.  Arch Intern Med. 1995;  155 (1) 97-103
    CrossrefPubMedGoogle Scholar
  • 191 Chaudhuri A, Behan P O. Fatigue in neurological disorders.  Lancet. 2004;  363 (9413) 978-988
    CrossrefPubMedGoogle Scholar
  • 192 Fox M D, Greicius M. Clinical applications of resting state functional connectivity.  Front Syst Neurosci. 2010;  4 19
    PubMedGoogle Scholar
  • 193 Wunder A, Klohs J, Dirnagl U. Non-invasive visualization of CNS inflammation with nuclear and optical imaging.  Neuroscience. 2009;  158 (3) 1161-1173
    CrossrefPubMedGoogle Scholar
  • 194 de Backer M E, Nabuurs R J, van Buchem M A, van der Weerd L. MR-based molecular imaging of the brain: the next frontier.  AJNR Am J Neuroradiol. 2010;  31 (9) 1577-1583
    CrossrefPubMedGoogle Scholar
  • 195 Modo M, Bulte J W. From molecules to man: the dawn of a vitreous man.  Methods Mol Biol. 2011;  711 3-14
    PubMedGoogle Scholar

Anthony L KomaroffM.D. 

Harvard Medical School, 10 Shattuck Street

2nd Floor, Boston, MA 02115

eMail: Komaroff@hms.harvard.edu